Canada Healthcare, Regulatory and Reimbursement Landscape – CountryFocus

GlobalData, the industry analysis specialist, has released its latest report: “Canada Healthcare, Regulatory and Reimbursement Landscape – CountryFocus”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Canada. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Canada, and includes:

• An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers

• Profiles and SWOT analyses of the major players in the pharmaceutical market: Johnson & Johnson, Novartis, Merck, Pfizer, and Apotex

• Profiles and SWOT analyses of the major players in the medical device market: GlaxoSmithKline, AstraZeneca, Stryker, EssilorLuxottica, and DePuy Synthes

• An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, HealthTech landscape, reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices

• Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure

• An overview of the opportunities for and challenges to growth in the Canadian healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to:

• Develop business strategies by understanding the trends shaping and driving Canada’s healthcare market

• Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Canada’s healthcare market in the future

• Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance

• Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership

Table of Contents

1 Table of Contents

1.1 List of Figures

1.2 List of Tables

2 Executive Summary

2.1 Executive Summary – Overview

2.2 Key Highlights

2.3 Key Highlights: Healthcare Start-Ups in Canada

2.4 Key Events: Canada Healthcare History, 2011-2020

2.5 Key Events: Canada Pharmaceutical Market

2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2019-2020

2.7 Key Events: Mergers and Acquisitions

2.8 Country Profile, Canada, 2019

3 Overview of Pharmaceutical Market

3.1 Pharmaceutical Market – Overview

3.2 Pharmaceutical Market – Exports

3.3 Pharmaceutical Market – Imports

3.4 Pharmaceutical Market – Supply Channels, Canada

3.5 Pharmaceutical Market – Market Segments

3.6 COVID-19 Epidemiology, Canada

3.7 Government Response to Mitigate COVID-19

3.8 COVID-19 Impact and Developments in Healthcare Market, Canada

3.9 COVID-19 IVD Market

3.10 Pharmaceutical Market – Major Players

4 Overview of Medical Devices Market

4.1 Medical Device Market – Overview

4.2 Medical Device Market – Major Segments

4.3 Medical Device Market – Major Players

5 Pharmaceutical and Medical Device Market – Drivers and Barriers

5.1 Drivers

5.2 Barriers

6 Deal analysis

6.1 Deal Analysis: M&A, VC, and PE Deals, Pharmaceutical Market, Canada 2019-2020

6.2 Deal Analysis: M&A, VC, and PE Deals, Medical Device Market, Canada 2019-2020

7 HealthTech Landscape

7.1 HealthTech Landscape

7.1.1 HealthTech Deals Landscape, Canada

7.2 Key HealthTech Deals, Canada

7.3 Adoption of Technology in Healthcare, Canada

7.4 Key Developments: Technology in Healthcare, Canada

7.5 HealthTech Landscape- Canada- Benefits and Risks

8 Market Access

8.1 Overview of Healthcare System, Canada

8.2 Reimbursement of Medicinal Products, Canada

8.3 Reimbursement of Medical Devices, Canada

8.4 Overview of Public Insurance Providers, Canada

8.5 Overview of Private Insurance Providers, Canada

8.6 Healthcare Spending and Health Price Index, Canada

8.7 Pricing Policies, Canada

8.8 Regulatory Landscape, Canada

8.8.1 Market Authorization for Pharmaceutical Drugs, Canada

8.8.2 Market Authorization for Medical Devices, Canada

8.8.3 Drug Establishment Licence Regulation, Canada

8.8.4 Medical Device Establishment Licence Regulation, Canada

8.8.5 Intellectual Property Rights, Patent, Canada

8.8.6 Intellectual Property Rights, Trademark, Canada

8.8.7 Pharmaceutical Clinical Trials Landscape, Canada

8.8.9 Medical Devices Clinical Trials Landscape, Canada

8.8.10 COVID-19 Clinical Trials, Canada

8.8.11 Clinical Trial Regulations, Canada

8.8.12 Pharmaceutical Advertising Regulations, Canada

8.8.13 Labeling and Packaging Regulations, Canada

9 Country Healthcare Landscape

9.1 Canada Healthcare Policy Highlights

9.2 Healthcare Facilities, Canada

9.3 Healthcare Parameters, Canada

9.4 Life Expectancy and Immunization Rate, Canada

9.5 Environmental Health, Canada

9.6 Healthcare Personnel, Canada

9.7 Disease Burden, Canada

9.8 Healthcare Expenditure

10 Trade Associations, Canada

11 Trade Fairs, Canada

12 Opportunities and Challenges

13 Appendix

13.1 Research Methodology

13.1.1 Coverage

13.1.2 Secondary Research

13.1.3 Forecasts

13.1.4 Expert Panel

13.2 Bibliography

13.3 Contact Us

13.4 Disclaimer

List of Tables

Table 1: Major Therapeutic Areas by Sales of Patented Drug Products, Canada, 2017

Table 2: COVID-19 Indicators (Number of cases), Global and Canada, 2020

Table 3: COVID-19 Nucleic Acid Amplification Tests (NAATs), Canada, 2020

Table 4: COVID-19 Enzyme Immuno Assay/Enzyme Linked Immunosorbent Assay (EIA/ELISA), Canada, 2020

Table 5: COVID-19 Point-of-Care (POC) Tests, Canada, 2020

Table 6: Polymerase Chain Reaction (PCR) Systems, Canada, 2020

Table 7: COVID-19 Other Equipment, Canada, 2020

Table 8: Medical Devices Market, Major Segments ($B), Canada, 2019

Table 9: Orthopedic Devices Market, Canada, Revenue ($M) and Market Share (%) of Major Companies, 2019

Table 10: Ophthalmic Devices Market, Canada, Revenue ($M) and Market Share (%) of Major Companies, 2019

Table 11: Healthcare IT Market, Canada, Revenue ($M) and Market Share (%) of Major Companies, 2019

Table 12: Drug Delivery Devices Market, Canada, Revenue ($M) and Market Share (%) of Major Companies, 2019

Table 13: General Surgery Market, Canada, Revenue ($M) and Market Share (%) of Major Companies, 2019

Table 14: List of Provincial Insurance Programs, Canada

Table 15: Fees for Examination of Drug Submission, Canada, 2020

Table 16: Fees for Right to Sell Drugs, Canada, 2020

Table 17: Fees for Examination of Medical Devices Licence Application, Canada, 2020

Table 18: Fees for Right to Sell Medical Devices, Canada, 2020

Table 19: Fees for Examination of Drug Establishment Licence, Canada, 2020

Table 20: Patent Fees, Canada, 2020

Table 21: Trademark Fees, Canada, 2020

Table 22: PAAB Advertisement Fees, Canada

Table 23: Label of a Pharmaceutical Main Panel, Canada

Table 24: Label of a Pharmaceutical Any Other Panel, Canada

Table 25: General Labeling of Medical Devices, Canada

Table 26: Outer Container Label of IVD Devices, Canada

Table 27: Immediate Container Label of IVD Devices, Canada

List of Figures

Figure 1: Pharmaceutical Market, Canada, Revenue ($B), 2012-2019

Figure 2: Medical Devices Market, Canada, Revenue ($B), 2015-2020

Figure 3: Healthcare Startups in Canada, 2020

Figure 4: Number of Deals (2019-2020)

Figure 5: 2019-2020 Deal Overview by Region

Figure 6: Country Profile, Canada, 2019

Figure 7: Pharmaceutical Market, Canada, Revenue ($B), 2012-2019

Figure 8: Pharmaceutical Market, Canada, Revenue Forecast ($B), 2020-2024

Figure 9: Pharmaceutical Exports ($B), Canada, 2012-2019

Figure 10: Top Export Partners, Canada, 2019

Figure 11: Pharmaceutical Imports ($B), Canada, 2012-2019

Figure 12: Top Import Partners, Canada, 2019

Figure 13: Pharmaceutical Market, Supply Channel, Canada, 2017

Figure 14: Generics Market, Canada, Revenue ($B), 2012-2018

Figure 15: Generic Drugs – Patented Drugs Share by Value, Canada, 2012-2018

Figure 16: Health Canada Approved Biologics, Canada, 2020

Figure 17: Health Canada Approved Biosimilars, Canada, 2020

Figure 18: OTC Market, Canada, Revenue ($B), 2012-2018

Figure 19: OTC Market by Drug Category, Canada, Revenue ($M), 2018

Figure 20: Major Therapeutic Areas by Sales of Patented Drug Products, Canada, 2017

Figure 21: COVID-19 (Number of cases), Canada, 2020

Figure 22: COVID-19 (Number of deaths), Canada, 2020

Figure 23: Medical Devices Market, Canada, Revenue ($B), 2015-2020

Figure 24: Medical Devices Market, Canada, Revenue Forecast ($B), 2021-2025

Figure 25: Medical Devices Market, Major Segments (%), Canada, 2019

Figure 26: Orthopedic Devices Market, Canada, Revenue ($B), 2015-2022

Figure 27: Orthopedic Devices Market, Canada, Market Share of Major Players (%), 2019

Figure 28: Ophthalmic Devices Market, Canada, Revenue ($B), 2015-2022

Figure 57: Deal Count ($M), HealthTech, Canada, 2019-2020

Figure 58: Organization of Health System, Canada, 2018

Figure 59: Common Drug Review Process, Canada, 2020

Figure 60: Pan-Canadian Oncology Drug Review Process, Canada, 2020

Figure 61: INESSS Evaluation Process For Registration, Canada, 2020

Figure 62: Drug Reimbursement Process, Canada, 2020

Figure 63: Medical Devices Reimbursement Process, Canada, 2020

Figure 64: OOP Expenditure (% of total expenditure on health), Canada, 2012-2017

Figure 65: Annual Rate of Change (%), Health Price Index, Canada, 2012-2017

Figure 66: HPFB Organizational Structure, Canada, 2019

Figure 67: CTD Format, Canada, 2020

Figure 68: New Drug Approval Process, Canada, 2020

Figure 69: New Medical Devices Approval Process, Canada, 2020

Figure 70: Licensing DEL Application Other Than ALR, Canada, 2020

Figure 71: Licensing DEL ALR Application, Canada, 2020

Figure 72: Medical Devices Establishment Licence, Canada, 2020

Figure 73: Patent Registration Process, Canada, 2019

Figure 74: Trademark Registration Process, Canada, 2019

Figure 75: Pharmaceutical Clinical Trials Count by Trial Status, Canada, 2019-2020

Figure 76: Pharmaceutical Clinical Trials Count by Phase, Canada, 2019-2020

Figure 77: Pharmaceutical Clinical Trials Count by Therapy Area, Canada, 2019-2020

Figure 78: Top Five Pharmaceutical Clinical Trials Sponsors by Count, Canada, 2019-2020

Figure 79: Medical Devices Clinical Trials Count by Trial Status, Canada, 2019-2020

Figure 80: Medical Devices Clinical Trials Count by Category, Canada, 2019-2020

Figure 81: Medical Devices Clinical Trials Count by Indication, Canada, 2019-2020

Figure 82: Top Five Medical Devices Clinical Trial Sponsors by Count, Canada, 2019-2020

Figure 83: Pharmaceutical Clinical Trials Count by Phase, Canada, 2019-2020

Figure 84: Top Five Pharmaceutical Clinical Trials Sponsors by Count, Canada, 2019-2020

Figure 85: Clinical Trial Regulation Process, Canada, 2019

Figure 86: PAAB Approval Process, Canada, 2020

Figure 87: Number of Hospitals, Canada, 2012-2017

Figure 88: Number of Diagnostic Equipment, Canada, 2015-2029

Figure 89: Total Hospital Beds (per 1,000 Population), Canada, 2012-2018

Figure 90: Acute Care Hospital Beds (per 1,000 Population), Canada, 2012-2018

Figure 91: Psychiatric Care Hospital Beds (per 1,000 Population), Canada, 2012-2018

Figure 92: Life Expectancy at Birth, Canada, 2012-2017

Figure 93: Immunization Rate (%), Canada, 2012-2018

Figure 94: PM2.5 (µg per m3), Canada, 2012-2017

Figure 95: CO2 Emissions (Million Tons), Canada, 2012-2018

Figure 96: Physicians (per 1,000 Population), Canada, 2012-2018

Figure 97: Dentists (per 1,000 Population), Canada, 2012-2017

Figure 98: Pharmacists (per 1,000 Population), Canada, 2012-2017

Figure 99: Nurses (per 1,000 Population), Canada, 2012-2017

Figure 100: Major Causes of Mortality (number of deaths), Canada, 2016

Figure 101: Major Causes of Male Mortality (number of deaths), Canada, 2016

Figure 102: Major Causes of Female Mortality (number of deaths), Canada, 2016

Figure 103: Disability-Adjusted Life Years by Major Disease (thousands), Canada, 2016

Figure 104: Healthcare Expenditure as Percentage of GDP (%), Canada, 2012-2018

Figure 105: Public-Private Share (%), Canada, 2012-2018

Figure 106: Major Components of Healthcare Spending (%), Canada, 2018

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Join our mailing list

Saved reports